GHK-Cu (Glycyl-L-Histidyl-L-Lysine Copper) is the anti-aging peptide that both dermatologists and longevity researchers respect — a rare combination. It's a naturally occurring copper-binding tripeptide your body produces abundantly when young, but levels decline ~60% between ages 20 and 70. Topically, it has one of the most robust evidence bases of any cosmetic ingredient — dozens of studies showing collagen synthesis stimulation, wound healing, and anti-aging effects on skin. Injectable GHK-Cu extends these benefits systemically, remodeling connective tissue and influencing gene expression in ways researchers describe as resetting genes toward a more youthful pattern.
GHK-Cu binds copper ions and delivers them to tissue, activating enzymes involved in collagen and elastin cross-linking. It stimulates fibroblast proliferation and collagen synthesis while regulating matrix metalloproteinases (MMPs) that break down collagen — resulting in more collagen, better-organized collagen, and reduced degradation. It also activates TGF-beta signaling and has been found to influence the expression of over 4,000 human genes, shifting them toward patterns associated with youth, repair, and anti-inflammation.
GHK-Cu may influence aging at the epigenetic level — the level of gene expression itself. Blood levels at 60 are roughly one-third of levels at 20. Research by Loren Pickart documented that GHK-Cu influences over 4,000 human genes (~31% of the genome), shifting them toward patterns of youth, repair, and anti-inflammation. Genes associated with tumor progression and cellular aging are downregulated; genes for antioxidant defense and repair are upregulated. In longevity protocols it serves as the "tissue and skin layer" — combined with Thymosin Alpha-1, NAD+, and GH peptides for a multi-system approach.
Topically: consistent improvements in skin texture, firmness, and wrinkle depth within 4–8 weeks. Hair: variable but frequently positive in early-stage thinning. Injectable: improved connective tissue tone, better overall skin quality, and reduced inflammatory markers over 8–12 week courses. Combining topical and injectable GHK-Cu provides the most comprehensive results.
Topical (no prescription): apply GHK-Cu serum 1–2x daily to face, neck, and hands. Look for 1–4% concentration. Injectable (prescription required): 1–2 mg subcutaneous 2–3x/week for 8–12 weeks on, 4–6 weeks off. Longevity stack: GHK-Cu injectable + CJC-1295/Ipamorelin + NAD+ + Thymosin Alpha-1.
Topical: among the safest skincare ingredients known with decades of consumer use. Injectable: standard injection site reactions (mild redness, swelling). Blue-green discoloration reported in older literature is associated with concentrations far above therapeutic doses and is not seen at standard dosing.